Loading...
Market
What will be the performance of 23andMe stock by March 31, 2025?
2
Resolution / Starting Odds
Stock increases by 10% or more • 25%
Stock remains within +/- 10% • 25%
Stock decreases by 10% or more • 25%
Stock remains volatile with no clear trend • 25%
Stock price data from financial market sources like Yahoo Finance
Story
23andMe Board Resigns Over CEO's Privatization Plan, Stock Down 7% ($ME)
Sep 18, 2024, 03:40 PM
All seven independent directors of 23andMe Holding Co. ($ME) have resigned from the company's board, citing a lack of progress on CEO Anne Wojcicki's proposal to take the company private. The resignations, effective immediately, were attributed to strategic differences and disappointment over Wojcicki's failure to provide an actionable buyout plan after five months of delays. The board members' departure follows an incomplete offer that was rejected in August. Wojcicki expressed surprise and disappointment at the mass resignation but remains committed to her privatization plan. This development comes after 23andMe settled a genetic privacy lawsuit for $30 million. Following the resignations, 23andMe's stock tumbled 7%.
View original story
Similar markets
Above 50% increase • 25%
10% to 50% increase • 25%
0% to 10% increase • 25%
Decrease • 25%
Outperforms NASDAQ • 25%
Performs on par with NASDAQ • 25%
Underperforms NASDAQ • 25%
Delisted from NASDAQ • 25%
Below $0.50 • 25%
$0.50 - $0.99 • 25%
$1.00 - $1.49 • 25%
$1.50 and above • 25%
Increase by more than 10% • 25%
Increase by less than 10% • 25%
Decrease by less than 10% • 25%
Decrease by more than 10% • 25%
Outperforms competitors • 25%
Matches competitors • 25%
Underperforms competitors • 25%
Significantly underperforms competitors • 25%
Less than $1 • 25%
$1 to $2 • 25%
$2 to $3 • 25%
More than $3 • 25%